<DOC>
	<DOCNO>NCT01612052</DOCNO>
	<brief_summary>The current recommended antibiotic , Cefazolin , treatment vascular surgery , provide coverage Methicillin-Sensitive Staphylococcus Aureaus ( MSSA ) , gram-positive bacteria , gram-negative bacteria may adequate antibiotic treatment time vascular surgery result increase hospital length stay , increase cost care , increase risk morbidity mortality consequence surgical site infection . Thus , investigator want compare whether Methicillin-resistant Staphylococcus Aureaus ( MRSA ) antibiotic prophylaxis Cefazolin plus Daptomycin superior Cefazolin plus Vancomycin reduction surgical site infection ( SSI ) follow open arterial revascularization procedure require groin plus low extremity incision . The investigator hypothesis Cefazolin plus Daptomycin superior Cefazolin plus Vancomycin prevention SSI high risk patient undergo open groin plus low extremity procedure .</brief_summary>
	<brief_title>Vascular Surgical Antibiotic Prophylaxis Study ( VSAPS 2 )</brief_title>
	<detailed_description>There increase surgical site infection ( SSI ) due MRSA . The current recommended antibiotic , Cefazolin , treatment vascular surgery , provide coverage Methicillin-Sensitive Staphylococcus Aureaus ( MSSA ) , gram-positive bacteria , gram-negative bacteria . To demonstrate MRSA coverage need vascular surgery prosthetic graft placement area body high risk infection , investigator initiate second study patient undergo groin plus low extremity procedure use combination antibiotic Cefazolin plus Daptomycin , Cefazolin plus Vancomycin . By decrease post surgical site prosthetic infection , investigator could significantly reduce vascular surgery mortality morbidity . Cost amputation rate investigator feel could also reduce . Patients randomize two group -- Cefazolin plus Daptomycin , Cefazolin plus Vancomycin evaluate post procedure discharge within 30 day 30 360 day , postoperative complication include cellulitis , graft infection , sepsis , limb loss , graft failure , length stay . If patient re-hospitalized , reason return whether related procedure evaluate . Additionally , graft failure , amputation , infection , hematoma , pseudoanurysm assess . In case wound infection , type organism finally , length hospitalization record .</detailed_description>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<mesh_term>Cefazolin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Age great 18 year Any elective arterial revascularization procedure involve one groin plus low extremity incision Further , patient 's consider high risk history MRSA colonization infection , HIV , admission &gt; 3 month acute care center longterm care center include study . Patient allergy Cefazolin , Daptomycin Vancomycin . Patients allergic Penicillin . Patients enrol another IRB approve biomedical study . Patients active infection require antibiotic preoperatively .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Vascular Surgery</keyword>
</DOC>